Literature DB >> 35612744

A Crosslinking Mass Spectrometry Protocol for the Structural Analysis of Microtubule-Associated Proteins.

Atefeh Rafiei1, David C Schriemer2,3.   

Abstract

Microtubule-associated proteins (MAPs) engage microtubules (MTs) to regulate both the MT state and wide variety of cytoskeletal functions. A comprehensive understanding of MAPs function requires the structural characterization of physical contacts MAPs make with other proteins, particularly when engaged with the microtubule (MT) lattice. Most of the interaction between MAPs and MTs evade classical structural determination techniques, as the interactions can be both heterogenous and sub-stoichiometric. Crosslinking mass spectrometry (XL-MS) can aid in MAP-MT structure analysis by providing a wealth of residue-based distance restraints. This protocol provides an XL-MS workflow for accurate and unbiased sampling of an equilibrated MAP-MT interaction, involving modifications to the preparation and validation of a MAP-MT construct suitable for crosslinking with fast-sampling heterobifunctional crosslinkers. The distance restrains obtained by this protocol can be used to generate accurate models assembled with an integrative structural modeling approach.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Crosslinking mass spectrometry; Integrative modeling; Microtubule-associated protein; Microtubules; Photo-crosslinking; Protein–protein interaction analysis; Structural mass spectrometry

Mesh:

Substances:

Year:  2022        PMID: 35612744     DOI: 10.1007/978-1-0716-2124-0_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Near-atomic cryo-EM structure of PRC1 bound to the microtubule.

Authors:  Elizabeth H Kellogg; Stuart Howes; Shih-Chieh Ti; Erney Ramírez-Aportela; Tarun M Kapoor; Pablo Chacón; Eva Nogales
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-04       Impact factor: 11.205

2.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

3.  High Sensitivity Crosslink Detection Coupled With Integrative Structure Modeling in the Mass Spec Studio.

Authors:  Vladimir Sarpe; Atefeh Rafiei; Morgan Hepburn; Nicholas Ostan; Anthony B Schryvers; David C Schriemer
Journal:  Mol Cell Proteomics       Date:  2016-07-13       Impact factor: 5.911

4.  Template-free 13-protofilament microtubule-MAP assembly visualized at 8 A resolution.

Authors:  Franck J Fourniol; Charles V Sindelar; Béatrice Amigues; Daniel K Clare; Geraint Thomas; Mylène Perderiset; Fiona Francis; Anne Houdusse; Carolyn A Moores
Journal:  J Cell Biol       Date:  2010-10-25       Impact factor: 10.539

5.  Structural basis for microtubule recognition by the human kinetochore Ska complex.

Authors:  Maria Alba Abad; Bethan Medina; Anna Santamaria; Juan Zou; Carla Plasberg-Hill; Arumugam Madhumalar; Uma Jayachandran; Patrick Marc Redli; Juri Rappsilber; Erich A Nigg; A Arockia Jeyaprakash
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

6.  Molecular architecture of the Dam1 complex-microtubule interaction.

Authors:  Thibault Legal; Juan Zou; Alicja Sochaj; Juri Rappsilber; Julie P I Welburn
Journal:  Open Biol       Date:  2016-03       Impact factor: 6.411

7.  The molecular architecture of the Dam1 kinetochore complex is defined by cross-linking based structural modelling.

Authors:  Alex Zelter; Massimiliano Bonomi; Jae Ook Kim; Neil T Umbreit; Michael R Hoopmann; Richard Johnson; Michael Riffle; Daniel Jaschob; Michael J MacCoss; Robert L Moritz; Trisha N Davis
Journal:  Nat Commun       Date:  2015-11-12       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.